4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-11-035999
Chief Executive Officer bought 10,000 shares at $4.40 ($43,962)
From the SEC's structured data for this filing
Trades in this filing
WEST MICHAEL D · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2011-06-22 | Purchase : show line 1 in the form | +10,000 | $4.40 | $43,962 | 79,600 | D |
| Open-market purchases · 10,000 sh · avg $4.40 · $43,962 | ||||||
Loading xslF345X03/doc4.xml…